Ajovy Coupons & Prices

Ajovy (fremanezumab-vfrm) is a brand-name injectable medication used to prevent migraine attacks before they start. It's a CGRP-blocking antibody self-injected once a month or once every three months, and there's no generic version since it's a biologic. If you're filling an Ajovy prescription, enter your ZIP above to see today's price and compare it against the manufacturer's savings program - an Ajovy coupon from Rx.com is worth checking even if you're eligible for the copay card.

What is Ajovy and how does it work?

Ajovy is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP), a molecule involved in transmitting migraine pain signals. By blocking CGRP, Ajovy reduces how often migraine attacks occur. It's given as a subcutaneous injection using a prefilled syringe or autoinjector, either monthly or as a larger dose every three months.

Ajovy is FDA-approved for the preventive treatment of migraine in adults, and for episodic migraine in children and adolescents 6 years and older who weigh at least 45 kg. It is a preventive treatment, not a rescue medication for an attack already underway.

Manufacturer savings card vs. an Rx.com cash coupon

Teva, the manufacturer of Ajovy, offers a savings program for commercially insured patients that can lower out-of-pocket costs; terms, eligibility, and the amount you pay vary and are set by Teva, so check the current terms directly through your provider or Teva's official Ajovy site. That card generally does not apply if you're uninsured or enrolled in Medicare or Medicaid.

If your insurance doesn't cover Ajovy, if the manufacturer card is declined, or if you're paying cash, an Rx.com coupon lets you compare pharmacy cash prices for Ajovy directly. Teva also sponsors a separate patient assistance program (Teva Cares Foundation) for eligible lower-income, uninsured patients - ask your provider's office about applying.

Alternatives to Ajovy

Ajovy is one of several injectable CGRP-targeting preventive migraine treatments. Others include Aimovig (erenumab), Emgality (galcanezumab), and the oral options Nurtec ODT (rimegepant) and Qulipta (atogepant). These medications aren't interchangeable - they differ in dosing schedule, route, and how they target the CGRP pathway - so switching between them is a decision for your neurologist or prescriber.

Safety information

Ajovy does not carry an FDA boxed warning. The most commonly reported side effects in clinical trials were injection-site reactions, such as pain, redness, or induration. Hypersensitivity reactions - including rash, itching, and hives - have occurred, most often within hours to a month of a dose; rare cases of angioedema and anaphylaxis have been reported after the drug reached the market. Ajovy is contraindicated in anyone with a serious hypersensitivity to fremanezumab-vfrm or its inactive ingredients.

This is general information, not medical advice. Tell your provider about any allergic reaction after an injection, and discuss your full medical history before starting Ajovy.